biothera_revSlide thumbnail

Pharmaceutical Inc.

Biothera Pharmaceutical Inc. is developing Imprime PGG, a clinical stage immunotherapeutic drug candidate that modulates key immune cells to recognize and kill cancer. Proof of concept has been established from randomized and single-arm phase 2 studies in non-small cell lung cancer, colorectal cancer, and chronic lymphocytic leukemia. Studies are ongoing in metastatic colorectal cancer and non-Hodgkin lymphoma.

Learn more »

Health Inc.

Wellmune®  is a natural food, beverage and supplement ingredient clinically proven to strengthen the immune system. A proprietary baker’s yeast beta 1,3/1,6 glucan, Wellmune is safe for everyday consumption and provides a range of health benefits for consumers of all ages. Wellmune is an award-winning brand available in products around the world. 

Learn more»